Wu Yong, Goh En Lin, Wang Dong, Ma Shaocheng
Leicester Medical School, University of Leicester, Leicester, UK.
Faculty of Medicine, Imperial College London, London, UK.
Open Access Rheumatol. 2018 Oct 4;10:135-140. doi: 10.2147/OARRR.S176666. eCollection 2018.
Osteoarthritis is the most prevalent chronic joint condition worldwide. The principles of osteoarthritis treatment are to alleviate pain and stiffness as well as maintain function, with current consensus guidelines recommending the use of a combination of conservative measures including physical therapy, analgesia, and surgical interventions such as arthroplasty. In recent years, several pharmacological therapies have emerged as potential alternatives. Although a disease-modifying osteoarthritis drug has yet to be identified, promising results have been reported in recent trials especially with serotonin-norepinephrine reuptake inhibitors, IL-1 antagonists, and antibodies to nerve growth factor. The present review aims to summarize and discuss the latest results of novel treatments for osteoarthritis and potential targets for future research.
骨关节炎是全球最常见的慢性关节疾病。骨关节炎的治疗原则是减轻疼痛和僵硬以及维持关节功能,目前的共识指南推荐采用包括物理治疗、镇痛等保守措施以及关节置换术等外科干预措施相结合的方法。近年来,几种药物治疗方法已成为潜在的替代方案。尽管尚未确定改变病情的骨关节炎药物,但近期试验已报告了一些有前景的结果,尤其是在使用5-羟色胺-去甲肾上腺素再摄取抑制剂、白细胞介素-1拮抗剂和神经生长因子抗体方面。本综述旨在总结和讨论骨关节炎新治疗方法的最新结果以及未来研究的潜在靶点。